Inflammatory bowel disease and elevated BMI may play causal roles in hidradenitis suppurativa, results of a Mendelian randomization study suggest. Medscape Medical News Source link : https://www.medscape.com/viewarticle/inflammatory-bowel-disease-and-increased-bmi-may-have-causal-2025a1000zjk?src=rss Author : Publish...

Available for over a yearWith the festive season approaching in parts of the world, Ruth Alexander explores what’s actually happening in the body during a hangover, why some people suffer...

(MedPage Today) -- The dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) was just as cardioprotective as the GLP-1 drug dulaglutide (Trulicity) in patients with type 2 diabetes and atherosclerotic cardiovascular...

(MedPage Today) -- Gout, the most common form of inflammatory arthritis, often coexists with comorbidities that require integrated assessment and treatment. The burden of cardiovascular-kidney-metabolic (CKM) comorbidities among adults with...

(MedPage Today) -- A model that combines a host biomarker with a generative artificial intelligence (AI) analysis of electronic medical records may improve the diagnosis of lower respiratory tract infections...

(MedPage Today) -- Higher intake of high-fat cheese and cream in midlife was tied to a lower risk of subsequent dementia, a 25-year study in Sweden showed. Adults who ate...

(MedPage Today) -- Four centrist Republicans broke with House Speaker Mike Johnson of Louisiana on Wednesday and signed onto a Democratic-led petition that will force a vote on extending for...

(MedPage Today) -- Two dose levels of maintenance treatment with extended-release buprenorphine (Sublocade) improved opioid abstinence in patients with high-risk opioid use disorder (OUD), a randomized trial showed. After two...

(MedPage Today) -- At the recent Maui Derm, George Martin, MD, founder and program director of the meeting, shared major developments in therapeutics for psoriatic disease -- particularly in the...

(MedPage Today) -- The FDA cleared a prescription smartphone app, dubbed LumosityRx, to help improve attention in adults with attention deficit-hyperactivity disorder (ADHD), maker Lumos Labs announced. Teva Pharmaceutical submitted...

(MedPage Today) -- The number of concierge and direct primary care practices in the U.S. rose sharply in recent years, as did the number of clinicians providing such care, researchers...

1 in 5 patients living with HIV on antiretroviral therapy reported experiencing undesired weight gain in the past 1 year, a new study finds. Medscape Medical News Source link :...

(MedPage Today) -- At the recent American Society of Hematology annual meeting, researchers presented data highlighting new behavioral and family-centered strategies to improve adherence to oral chemotherapy in pediatric acute...

A noninvasive AI tool may be able to predict potential cardiovascular events in patients with suspected stable coronary artery disease, according findings from the FISH&CHIPS study presented at the EACVI...

(MedPage Today) -- A fully remote tailored weight-loss program showed potential for helping veterans with obesity and serious mental illness lose weight, a randomized trial showed. Among 256 veterans, weight...

(MedPage Today) -- Dana-Farber Cancer Institute will pay $15 million to resolve allegations it violated the False Claims Act by making materially false statements and certifications related to NIH research...

(MedPage Today) -- The FDA approved a label change for the birth control shot depot medroxyprogesterone acetate (Depo-Provera), which now warns about the risk of meningioma, according to a letter...

An artist’s impression of PSR J2322-2650bNASA, ESA, CSA, Ralf Crawford (STScI) Astronomers have found what appears to be one of the strangest known worlds in the universe. It orbits a...

(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. FDA Travel Spending During Shutdown Draws Scrutiny The...

In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with prurigo nodularis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/first-class-monoclonal-antibody-safe-effective-patients-2025a1000zg6?src=rss Author : Publish date : 2025-12-17...